DIGitoxin 改善晚期慢性心力衰竭 (DIGIT-HF) 患者的结果:与最近随机对照心力衰竭试验相比,基线特征
Udo Bavendiek1, Nele Henrike Thomas2, Dominik Berliner1
1Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
European journal of heart failure
|May 19, 2025
概括
DIGIT-HF试验招募了心力衰竭和减少喷射率 (HFrEF) 的患者,这些患者的症状比最近的试验更严重,设备植入率更高. 药物治疗的使用在所有研究中都是相似的.
科学领域:
- 心脏病学 心脏病学
- 临床试验 临床试验
- 心脏衰竭研究研究
背景情况:
- DIGIT-HF试验调查了减少喷射分数 (HFrEF) 的心力衰竭中digitoxin的疗效.
- 了解患者的基线特征对于解释试验结果和将其与现有文献进行比较至关重要.
研究的目的:
- 介绍DIGIT-HF试验中患者的基线特征.
- 将这些特征与最近的HFrEF试验的参与者进行比较,这些参与者报告了改善的结果.
主要方法:
- DIGIT-HF是一个随机,双盲,安慰剂控制的多中心试验.
- 纳入了具有症状HFrEF (NYHAII-IV类,LVEF≤30-40%) 的患者.
- 分析了基线人口统计数据,临床状态和药物/设备使用情况.
主要成果:
- 该DIGIT-HF群体 (1212名患者) 的平均年龄为66岁,20%是女性,平均LVEF为29%.
- 与最近的HFrEF试验相比,患者呈现出更严重的症状 (NYHAII-IV类分布:30%,66%,4%).
- 观察到高率的指导方针导向医疗疗 (GDMT),其中96%用于β抑制剂,95%用于ACEi/ARBs/RNAIs.
- 植入式心脏转换器-除器 (ICD) 和心脏再同步治疗 (CRT) 设备植入率显著更高 (分别为64%和25%).
结论:
- 在DIGIT-HF试验中的患者表现出比比较HFrEF试验中的患者更大的症状负担和更高的设备利用率.
- 药物治疗方案与最近的试验中的方案相似,这表明在这个队列中专注于设备治疗.
相关概念视频
01:26Heart Failure Drugs: Inotropic Agents
2.0K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
01:22Heart Failure Drugs: Diuretics
1.8K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.8K
01:30Heart Failure IV: Classification and Diagnostic Evaluation
1.2K
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.2K
01:30Heart Failure V: Medical Management
641
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
641
01:22Heart Failure VI: Adjunct Therapies
635
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
635
01:30Cardiomyopathy II: Dilated Cardiomyopathy
798
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798